Lifetime Management in Low- And Intermediate-Risk TAVI: Insights on Navitor and the VANTAGE Data | B. Gonska
Watch B. Gonska stressing the importance of procedural safety, excellent haemodynamics, valve durability and preserved coronary access when treating younger, low- and intermediate-risk TAVI patients. Navitor™’is presented, reviewing the VANTAGE trial data with single-digit gradients, low complication rates and minimal PVL, confirming Navitor™’s safety and value for lifetime management.
LEARN MORE:
Related Videos
Procedural tip & tricks with Navitor across all valve sizes
Transcatheter Aortic Valves Implant
1-year VANTAGE TAVI outcomes in low/intermediate-risk patients
A Defining Moment Has To Start Somewhere. Why Not With You?
Webinar for Collaborative Management of HF Patients with MR
Transcatheter tricuspid valve repair: Cases, tips and tricks
M-TEER: Best treatment strategies for FMR AND DMR
Latest evidence in patient selection for T-TEER
TRENDING TOPICS
Procedural tip & tricks with Navitor across all valve sizes
1-year VANTAGE TAVI outcomes in low/intermediate-risk patients
Transcatheter Aortic Valves Implant
